ENTA vs TROW · rev $65.3M vs P/E 12, rev $3.76B
Enanta Pharmaceuticals Inc (ENTA) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. ENTA currently screens at market cap $328.0M.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
ENTA currently screens at market cap $328.0M. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the ENTA and TROW stock pages for the full models.
Not investment advice.